• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correction to: PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance.

作者信息

Feng Chenchen, Li Yuqing, Li Kunping, Lyu Yinfeng, Zhu Wenhui, Jiang Haowen, Wen Hui

机构信息

Department of Urology, Huashan Hospital, Fudan University, 12 Middle Urumqi Rd, 200040, Shanghai, PR China.

Institute of Urology, Fudan University, 200040, Shanghai, PR China.

出版信息

J Exp Clin Cancer Res. 2021 Dec 2;40(1):379. doi: 10.1186/s13046-021-02165-5.

DOI:10.1186/s13046-021-02165-5
PMID:34857034
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8638483/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4749/8638483/4ea4b552461f/13046_2021_2165_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4749/8638483/4ea4b552461f/13046_2021_2165_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4749/8638483/4ea4b552461f/13046_2021_2165_Fig1_HTML.jpg

相似文献

1
Correction to: PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance.对《PFKFB4在透明细胞肾细胞癌中过表达促进磷酸戊糖途径介导舒尼替尼耐药》一文的修正
J Exp Clin Cancer Res. 2021 Dec 2;40(1):379. doi: 10.1186/s13046-021-02165-5.
2
6-Phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 and 4: A pair of valves for fine-tuning of glucose metabolism in human cancer.6-磷酸果糖-2-激酶/果糖-2,6-二磷酸酶 3 和 4：精细调节人类癌症中葡萄糖代谢的一对阀门。
Mol Metab. 2019 Feb;20:1-13. doi: 10.1016/j.molmet.2018.11.013. Epub 2018 Dec 5.
3
Investigation of Metabolomic Changes in Sunitinib-Resistant Human Renal Carcinoma 786-O Cells by Capillary Electrophoresis-Time of Flight Mass Spectrometry.采用毛细管电泳-飞行时间质谱法研究舒尼替尼耐药人肾癌786-O细胞的代谢组学变化
Biol Pharm Bull. 2018;41(4):619-627. doi: 10.1248/bpb.b17-00992.
4
Metabolomic profile of glycolysis and the pentose phosphate pathway identifies the central role of glucose-6-phosphate dehydrogenase in clear cell-renal cell carcinoma.糖酵解和磷酸戊糖途径的代谢组学特征确定了6-磷酸葡萄糖脱氢酶在透明细胞肾细胞癌中的核心作用。
Oncotarget. 2015 May 30;6(15):13371-86. doi: 10.18632/oncotarget.3823.
5
Role of IL13RA2 in Sunitinib Resistance in Clear Cell Renal Cell Carcinoma.白细胞介素13受体A2（IL13RA2）在透明细胞肾细胞癌对舒尼替尼耐药中的作用
PLoS One. 2015 Jun 26;10(6):e0130980. doi: 10.1371/journal.pone.0130980. eCollection 2015.
6
Enhanced expression of caveolin-1 possesses diagnostic and prognostic value and promotes cell migration, invasion and sunitinib resistance in the clear cell renal cell carcinoma.小窝蛋白-1的表达增强具有诊断和预后价值，并促进透明细胞肾细胞癌的细胞迁移、侵袭和舒尼替尼耐药。
Exp Cell Res. 2017 Sep 15;358(2):269-278. doi: 10.1016/j.yexcr.2017.07.004. Epub 2017 Jul 3.
7
Integrated mRNA and miRNA Transcriptomic Analyses Reveals Divergent Mechanisms of Sunitinib Resistance in Clear Cell Renal Cell Carcinoma (ccRCC).整合的mRNA和miRNA转录组分析揭示了透明细胞肾细胞癌（ccRCC）中舒尼替尼耐药的不同机制。
Cancers (Basel). 2021 Aug 31;13(17):4401. doi: 10.3390/cancers13174401.
8
CRISPR-mediated ablation of overexpressed EGFR in combination with sunitinib significantly suppresses renal cell carcinoma proliferation.CRISPR 介导的过表达 EGFR 基因敲除联合舒尼替尼显著抑制肾细胞癌增殖。
PLoS One. 2020 May 15;15(5):e0232985. doi: 10.1371/journal.pone.0232985. eCollection 2020.
9
Overexpression of miR-15b Promotes Resistance to Sunitinib in Renal Cell Carcinoma.miR-15b的过表达促进肾细胞癌对舒尼替尼的耐药性。
J Cancer. 2019 Jun 9;10(15):3389-3396. doi: 10.7150/jca.31676. eCollection 2019.
10
RCAN1.4 acts as a suppressor of cancer progression and sunitinib resistance in clear cell renal cell carcinoma.RCAN1.4 作为透明细胞肾细胞癌中肿瘤进展和舒尼替尼耐药的抑制剂。
Exp Cell Res. 2018 Nov 15;372(2):118-128. doi: 10.1016/j.yexcr.2018.09.017. Epub 2018 Sep 27.

引用本文的文献

1
Sulforaphane-cysteine inhibits α-tubulin/PD-L1/PFKFB4 axis leading to apoptosis in human glioblastoma.萝卜硫素-半胱氨酸抑制α-微管蛋白/程序性死亡配体1/6-磷酸果糖-2-激酶/果糖-2,6-二磷酸酶4轴，导致人胶质母细胞瘤细胞凋亡。
Med Oncol. 2025 Jul 14;42(8):333. doi: 10.1007/s12032-025-02901-3.
2
CD151 interacts with integrin beta 2 in B cell lymphomas.在B细胞淋巴瘤中，CD151与整合素β2相互作用。
Cell Mol Life Sci. 2025 Jun 4;82(1):221. doi: 10.1007/s00018-025-05747-0.
3
The pathogenesis and therapeutic implications of metabolic reprogramming in renal cell carcinoma.

本文引用的文献

1
PFKFB4 is overexpressed in clear-cell renal cell carcinoma promoting pentose phosphate pathway that mediates Sunitinib resistance.PFKFB4 在肾透明细胞癌中过表达，促进戊糖磷酸途径，介导舒尼替尼耐药。
J Exp Clin Cancer Res. 2021 Sep 30;40(1):308. doi: 10.1186/s13046-021-02103-5.
肾细胞癌中代谢重编程的发病机制及治疗意义
Cell Death Discov. 2025 Apr 19;11(1):186. doi: 10.1038/s41420-025-02479-9.
4
Effect of PFKFB4 on the Prognosis and Immune Regulation of NSCLC and Its Mechanism.PFKFB4对非小细胞肺癌预后及免疫调节的影响及其机制
Int J Gen Med. 2022 Aug 2;15:6341-6353. doi: 10.2147/IJGM.S369126. eCollection 2022.